Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

526 public trials 91 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

NCT06697184

Conditions
CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT06588478

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope National Medical Center Irvine, California, United States
  • Palo Alto Medical Foundation Research Institute (PAMFRI) Palo Alto, California, United States
View all 131 locations
View Trial Details
Recruiting

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

NCT04771572

Conditions
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +48 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

NCT04560322

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT06428019

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Arizona Oncology - Tucson - Rudasill /ID# 267552 Tucson, Arizona, United States
  • Southern VA Health Care System /ID# 266254 Tucson, Arizona, United States
  • UCSF FRESNO/Community Cancer Institute /ID# 270874 Clovis, California, United States
  • Valkyrie Clinical Trials /ID# 268151 Los Angeles, California, United States
View all 70 locations
View Trial Details

Related conditions